The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. More
Articles
7 of the Most Undervalued Mid-Cap Stocks to Buy Now
Here are seven undervalued mid-cap stocks that are likely to benefit from stable or increasing consumer demand. More
Don’t Buy Nvidia Until the Downtrend Turns
Nvidia shares are now 50% off their highs, but don't buy them just yet. Here's what to consider before picking up NVDA stock. More
Finding the Silver Lining
Why Louis Navellier is optimistic … the case for a short bear market … signs that the smart money is already buying in this “divergence” opportunity While it’s hard to remain optimistic in the current market environment, I encourage you to remain patient and not panic-sell like the rest of Wall Street. The reality is… More
Finding Hope in Growth Play Aterian Stock
ATER stock hasn't performed particularly strongly, but it can still surprise. That means another short squeeze could be near. More